Analyst Ratings For NASDAQ:ONCE – Spark Therapeutics (NASDAQ:ONCE)
Today, Leerink Swann reiterated its Market Perform rating on NASDAQ:ONCE – Spark Therapeutics (NASDAQ:ONCE) with a price target of $55.00 ➝ $74.00.
Some recent analyst ratings include
- 5/7/2018-Leerink Swann Reiterated Rating of Market Perform.
- 5/1/2018-Citigroup initiated coverage with a Neutral ➝ Neutral rating.
- 5/1/2018-Mizuho Reiterated Rating of Buy.
- 4/30/2018-Cantor Fitzgerald Reiterated Rating of Overweight ➝ Buy.
- 4/23/2018-Chardan Capital was Downgraded by analysts at Chardan Capital from a “Buy ➝ Neutral” rating to a “” rating. They now have a $80.00 ➝ $85.00 price target on the stock.
- 4/19/2018-William Blair Reiterated Rating of Buy.
- On 4/20/2018 John Furey, COO, sold 6,723 with an average share price of $82.50 per share and the total transaction amounting to $554,647.50.
- On 4/18/2018 John Furey, COO, sold 13,277 with an average share price of $82.52 per share and the total transaction amounting to $1,095,618.04.
- On 4/12/2018 John Furey, COO, sold 20,000 with an average share price of $77.51 per share and the total transaction amounting to $1,550,200.00.
- On 12/11/2017 John Furey, COO, sold 18 with an average share price of $46.33 per share and the total transaction amounting to $833.94.
- On 12/8/2017 John Furey, COO, bought 18 with an average share price of $73.48 per share and the total transaction amounting to $1,322.64.
- On 11/28/2017 Katherine A High, Insider, sold 5,000 with an average share price of $71.32 per share and the total transaction amounting to $356,600.00.
- On 11/16/2017 Stephen W Webster, CFO, sold 10,000 with an average share price of $70.14 per share and the total transaction amounting to $701,400.00.
Recent Trading Activity for NASDAQ:ONCE – Spark Therapeutics (NASDAQ:ONCE)
Shares of NASDAQ:ONCE – Spark Therapeutics closed the previous trading session at 72.85 up +2.18 3.08% with 71.33999633789062 shares trading hands.